FI106379B - Menetelmä valmistaa ihmisen valkosoluelastaasi-inhibiittorina käytettäviä trifluorimetyyliketonijohdoksia - Google Patents

Menetelmä valmistaa ihmisen valkosoluelastaasi-inhibiittorina käytettäviä trifluorimetyyliketonijohdoksia Download PDF

Info

Publication number
FI106379B
FI106379B FI915996A FI915996A FI106379B FI 106379 B FI106379 B FI 106379B FI 915996 A FI915996 A FI 915996A FI 915996 A FI915996 A FI 915996A FI 106379 B FI106379 B FI 106379B
Authority
FI
Finland
Prior art keywords
compound
valyl
formula
amino
trifluoro
Prior art date
Application number
FI915996A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI915996A (fi
FI915996A0 (fi
Inventor
Keiji Hemmi
Keisuke Imai
Hirokazu Tanaka
Ichiro Shima
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909028231A external-priority patent/GB9028231D0/en
Priority claimed from GB919119713A external-priority patent/GB9119713D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI915996A0 publication Critical patent/FI915996A0/fi
Publication of FI915996A publication Critical patent/FI915996A/fi
Application granted granted Critical
Publication of FI106379B publication Critical patent/FI106379B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
  • Magnetically Actuated Valves (AREA)
FI915996A 1990-12-31 1991-12-19 Menetelmä valmistaa ihmisen valkosoluelastaasi-inhibiittorina käytettäviä trifluorimetyyliketonijohdoksia FI106379B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB909028231A GB9028231D0 (en) 1990-12-31 1990-12-31 Trifluoromethylketone derivatives,processes for preparation thereof and use thereof
GB9028231 1990-12-31
GB9119713 1991-09-16
GB919119713A GB9119713D0 (en) 1991-09-16 1991-09-16 Trifluoremethylketone derivatives, processes for preparation thereof and use thereof

Publications (3)

Publication Number Publication Date
FI915996A0 FI915996A0 (fi) 1991-12-19
FI915996A FI915996A (fi) 1992-07-01
FI106379B true FI106379B (fi) 2001-01-31

Family

ID=26298196

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915996A FI106379B (fi) 1990-12-31 1991-12-19 Menetelmä valmistaa ihmisen valkosoluelastaasi-inhibiittorina käytettäviä trifluorimetyyliketonijohdoksia

Country Status (19)

Country Link
US (2) US5296591A (ru)
EP (1) EP0494071B1 (ru)
JP (1) JPH0699378B2 (ru)
KR (1) KR100192991B1 (ru)
CN (1) CN1040003C (ru)
AT (1) ATE151775T1 (ru)
AU (1) AU641577B2 (ru)
CA (1) CA2058560C (ru)
DE (1) DE69218977T2 (ru)
DK (1) DK0494071T3 (ru)
ES (1) ES2099755T3 (ru)
FI (1) FI106379B (ru)
GR (1) GR3023719T3 (ru)
HU (2) HU210263B (ru)
IE (1) IE914360A1 (ru)
MX (1) MX9102612A (ru)
NO (1) NO309274B1 (ru)
RU (1) RU2073684C1 (ru)
SG (1) SG50457A1 (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
US5714470A (en) 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
FR2694295B1 (fr) * 1992-07-28 1994-09-02 Adir Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent.
FR2719589B1 (fr) * 1994-05-05 1996-06-14 Adir Nouveaux peptides dérivés de trifluorométhylcétones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
EP0763055B1 (en) * 1994-06-02 1999-11-03 Merrell Pharmaceuticals Inc. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
NZ287604A (en) * 1994-06-02 1998-12-23 Merrell Pharma Inc Acylated enol derivatives as prodrugs of elastase inhibitors
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
JP4320791B2 (ja) * 1998-02-24 2009-08-26 アステラス製薬株式会社 皮ふの老化の予防、治療剤
US20020045231A1 (en) * 1999-02-02 2002-04-18 Napper Andrew D. Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
WO2001026685A1 (fr) * 1999-10-12 2001-04-19 Fujisawa Pharmaceutical Co., Ltd. Remedes pour plaies chroniques
IL148924A (en) * 2002-03-26 2015-06-30 Mor Research Applic Ltd Use of substances that inhibit intracellular elastase activity in the preparation of a drug for the treatment and / or prevention of necrosis of cells and related diseases
DE10219464A1 (de) 2002-04-30 2003-11-13 Focke & Co Zigarettenpackung
SE0202462D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab Novel use
PL2019837T3 (pl) * 2006-05-23 2011-09-30 Irm Llc Związki i kompozycje jako inhibitory proteazy aktywującej kanały
WO2008023446A1 (fr) * 2006-08-25 2008-02-28 Stelic Institute Of Regenerative Medicine, Stelic Institute & Co. Remède pour des bronchopneumopathies chroniques obstructives
EP2099454A4 (en) * 2006-11-17 2010-11-10 Abbott Lab AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS
JP5819305B2 (ja) * 2009-10-13 2015-11-24 リガンド・ファーマシューティカルズ・インコーポレイテッド 造血成長因子模倣小分子化合物およびそれらの使用
NZ714111A (en) * 2013-05-08 2019-03-29 Kissei Pharmaceutical Alpha-substituted glycinamide derivative
CN104650016A (zh) * 2015-01-29 2015-05-27 武汉大学 拟三肽类化合物及其制备方法
EP3476381B1 (en) 2016-06-24 2021-12-22 Pola Chemical Industries Inc. External preparation for skin for wrinkle improvement
JP7133564B2 (ja) 2017-11-15 2022-09-08 ポーラ化成工業株式会社 油性組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
US5221665A (en) * 1989-10-27 1993-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. N-substituted amides
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof

Also Published As

Publication number Publication date
JPH04297446A (ja) 1992-10-21
CN1040003C (zh) 1998-09-30
CN1063108A (zh) 1992-07-29
CA2058560A1 (en) 1992-07-01
NO309274B1 (no) 2001-01-08
GR3023719T3 (en) 1997-09-30
NO920035L (no) 1992-07-01
FI915996A (fi) 1992-07-01
AU8985391A (en) 1992-07-02
ES2099755T3 (es) 1997-06-01
US5296591A (en) 1994-03-22
KR100192991B1 (ko) 1999-06-15
FI915996A0 (fi) 1991-12-19
EP0494071A3 (en) 1993-05-05
DK0494071T3 (ru) 1997-05-12
HU914153D0 (en) 1992-03-30
KR920011988A (ko) 1992-07-25
ATE151775T1 (de) 1997-05-15
DE69218977D1 (de) 1997-05-22
NO920035D0 (no) 1992-01-02
US5430025A (en) 1995-07-04
EP0494071A2 (en) 1992-07-08
HU211943A9 (en) 1996-01-29
EP0494071B1 (en) 1997-04-16
HU210263B (en) 1995-03-28
SG50457A1 (en) 1998-07-20
IE914360A1 (en) 1992-07-01
CA2058560C (en) 2000-12-12
AU641577B2 (en) 1993-09-23
DE69218977T2 (de) 1997-08-07
HUT60507A (en) 1992-09-28
RU2073684C1 (ru) 1997-02-20
MX9102612A (es) 1992-06-01
JPH0699378B2 (ja) 1994-12-07

Similar Documents

Publication Publication Date Title
FI106379B (fi) Menetelmä valmistaa ihmisen valkosoluelastaasi-inhibiittorina käytettäviä trifluorimetyyliketonijohdoksia
US5254558A (en) Substituted 1,3-diazines as leukocyte elastase inhibitors
JP5558710B2 (ja) Ｈｄａｃ阻害剤としてのｆｋ２２８誘導体
RU2266901C2 (ru) 4-пиримидинил-n-ацил-l-фенилаланины и фармацевтическая композиция
JPH0437070B2 (ru)
WO1995000535A1 (en) Optically pure calpain inhibitor compounds
RU2270193C2 (ru) 4-пиридинил-n-ацил-l-фенилаланины
CA2216162A1 (en) Piperazinones useful as inhibitors of platelet aggregation
JP2002535394A (ja) トリプターゼインヒビターとして有用なペプチジル複素環式ケトン
JPH02279661A (ja) アミノ酸誘導体
ES2228472T3 (es) Derivados de beta-alanina.
AU709088B2 (en) Thrombin inhibitors
IE45095B1 (en) Dipeptide derivatives
US6417161B1 (en) Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
FR2540866A1 (fr) Acides aminocetone carboxyliques utilisables comme intermediaires pour la preparation de peptides substitues
JPS595150A (ja) 抗微生物性ジスルフイドプロドラツグ
EP0055846B1 (en) New peptide, process for preparation thereof and pharmaceutical composition containing it
EP2054402B1 (en) An aminoisoquinoline thrombin inhibitor with improved bioavailability
JPH07242624A (ja) 新規なアゼチジノン誘導体
JP2017518290A (ja) β−アレスチンエフェクターの合成
JPH08119922A (ja) ｏ−ピバロイル−チロシン誘導体
JPH07316056A (ja) エラスターゼ阻害用医薬組成物
JPH029863A (ja) トリ置換−１，２，３，４−テトラヒドロイソキノリン
JP2001518466A (ja) トロンビン阻害薬
JPS61176573A (ja) 新規なアミノ酸誘導体

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ASTELLAS PHARMA INC.

Free format text: ASTELLAS PHARMA INC.